Filtered By:
Therapy: Antiviral Therapy
This page shows you your search results in order of date.
Order by Relevance | Date
Total 2209 results found since Jan 2013.
A quick algorithmic review on management of viral infectious diseases in pediatric solid organ transplant recipients
Front Pediatr. 2023 Sep 4;11:1252495. doi: 10.3389/fped.2023.1252495. eCollection 2023.ABSTRACTPediatric solid organ transplant is a life-saving procedure for children with end-stage organ failure. Viral infections are a common complication following pediatric solid organ transplantation (SOT), which can lead to increased morbidity and mortality. Pediatric solid organ transplant recipients are at an increased risk of viral infections due to their immunosuppressed state. The most commonly encountered viruses include cytomegalovirus (CMV), Epstein-Barr virus (EBV), herpes simplex virus (HSV), varicella-zoster virus (VZV), ad...
Source: Herpes - September 21, 2023 Category: Infectious Diseases Authors: Marjan Moghadamnia Hamid Eshaghi Hosein Alimadadi Simin Dashti-Khavidaki Source Type: research
Prevention and management of hepatitis B virus reactivation in patients with hematological malignancies in the targeted therapy era
World J Gastroenterol. 2023 Sep 7;29(33):4942-4961. doi: 10.3748/wjg.v29.i33.4942.ABSTRACTHepatitis due to hepatitis B virus (HBV) reactivation can be serious and potentially fatal, but is preventable. HBV reactivation is most commonly reported in patients receiving chemotherapy, especially rituximab-containing therapy for hematological malignancies and those receiving stem cell transplantation. Patients with inactive and even resolved HBV infection still have persistence of HBV genomes in the liver. The expression of these silent genomes is controlled by the immune system. Suppression or ablation of immune cells, most imp...
Source: World Journal of Gastroenterology : WJG - September 21, 2023 Category: Gastroenterology Authors: Joyce Wing Yan Mak Alvin Wing Hin Law Kimmy Wan Tung Law Rita Ho Carmen Ka Man Cheung Man Fai Law Source Type: research
Clinical and Epidemiological Profile of Herpes Zoster and Its Complications in a Tertiary Care Center of Bihar: A Prospective Study
Conclusion A broader understanding of the clinical and epidemiological factors of herpes zoster and post-herpetic complications is important as this disease constitutes a considerable burden in a tertiary care center and if not treated adequately, the after-effects might last for many years altogether. Hence, early diagnosis and initiation of adequate antiviral therapy as well as pain management is the key aspect of management.PMID:37719532 | PMC:PMC10503883 | DOI:10.7759/cureus.43560
Source: Herpes - September 18, 2023 Category: Infectious Diseases Authors: Rajesh Sinha Pinki Kumari U K Pallavi Subhasree Sarkar Source Type: research
Atypical Varicella-Zoster Virus Reactivation: A Case Report
Eur J Case Rep Intern Med. 2023 Aug 11;10(9):003945. doi: 10.12890/2023_003945. eCollection 2023.ABSTRACTVaricella-zoster virus (VZV) commonly causes benign skin manifestations in children; it then establishes a latent infection and may reactivate, causing herpes zoster. The most common zoster complication is postherpetic neuralgia, but complications can also occur without a rash. VZV infection may cause neurological manifestations and even vasculopathy may occur, in both primary and reactivated VZV infection. Thrombotic complications are mainly described in children, while a few case reports have described cerebral venous...
Source: Herpes - September 8, 2023 Category: Infectious Diseases Authors: Francesca Salvotti Simone Trapletti Giulia Chiarini Maurizio Castellano Maria Lorenza Muiesan Source Type: research
Antiviral activity of taurisolo ® during bovine alphaherpesvirus 1 infection
In conclusion, our findings indicate that Taurisolo® may represent a potential antiviral agent against BoAHV-1 infection. Noteworthy, AhR could be involved in the observed effects and become a new target in antiviral therapy.PMID:37666327 | DOI:10.1016/j.virusres.2023.199217
Source: Virus Research - September 4, 2023 Category: Virology Authors: Claudia Cerracchio Maria Grazia Amoroso Marialuisa Piccolo Maria Grazia Ferraro Francesca Paola Nocera Luisa De Martino Francesco Serra Carlo Irace Gian Carlo Tenore Ettore Novellino Rita Santamaria Filomena Fiorito Source Type: research
Antiviral activity of taurisolo ® during bovine alphaherpesvirus 1 infection
In conclusion, our findings indicate that Taurisolo® may represent a potential antiviral agent against BoAHV-1 infection. Noteworthy, AhR could be involved in the observed effects and become a new target in antiviral therapy.PMID:37666327 | DOI:10.1016/j.virusres.2023.199217
Source: Cell Research - September 4, 2023 Category: Cytology Authors: Claudia Cerracchio Maria Grazia Amoroso Marialuisa Piccolo Maria Grazia Ferraro Francesca Paola Nocera Luisa De Martino Francesco Serra Carlo Irace Gian Carlo Tenore Ettore Novellino Rita Santamaria Filomena Fiorito Source Type: research
Antiviral therapy of coronavirus disease 2019 (COVID-19)
J Formos Med Assoc. 2023 Sep 2:S0929-6646(23)00342-X. doi: 10.1016/j.jfma.2023.08.029. Online ahead of print.ABSTRACTThe coronavirus disease 2019 (COVID-19) pandemic has reached a turning point. The non-pharmaceutical interventions for preventing COVID-19 are lifting. Vaccination uptake is increasing in general, but this strategy is continuously challenged by the rapid evolution of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Of note, the Omicron subvariants spread globally for at least one year, and the most recently developed subvariants show strong immune evasion to preexisting immunity, either from pre...
Source: J Formos Med Assoc - September 4, 2023 Category: General Medicine Authors: Pao-Yu Chen Jann-Tay Wang Shan-Chwen Chang Source Type: research
Antiviral activity of taurisolo ® during bovine alphaherpesvirus 1 infection
In conclusion, our findings indicate that Taurisolo® may represent a potential antiviral agent against BoAHV-1 infection. Noteworthy, AhR could be involved in the observed effects and become a new target in antiviral therapy.PMID:37666327 | DOI:10.1016/j.virusres.2023.199217
Source: Virus Research - September 4, 2023 Category: Virology Authors: Claudia Cerracchio Maria Grazia Amoroso Marialuisa Piccolo Maria Grazia Ferraro Francesca Paola Nocera Luisa De Martino Francesco Serra Carlo Irace Gian Carlo Tenore Ettore Novellino Rita Santamaria Filomena Fiorito Source Type: research
Antiviral therapy of coronavirus disease 2019 (COVID-19)
J Formos Med Assoc. 2023 Sep 2:S0929-6646(23)00342-X. doi: 10.1016/j.jfma.2023.08.029. Online ahead of print.ABSTRACTThe coronavirus disease 2019 (COVID-19) pandemic has reached a turning point. The non-pharmaceutical interventions for preventing COVID-19 are lifting. Vaccination uptake is increasing in general, but this strategy is continuously challenged by the rapid evolution of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Of note, the Omicron subvariants spread globally for at least one year, and the most recently developed subvariants show strong immune evasion to preexisting immunity, either from pre...
Source: J Formos Med Assoc - September 4, 2023 Category: General Medicine Authors: Pao-Yu Chen Jann-Tay Wang Shan-Chwen Chang Source Type: research
Antiviral activity of taurisolo ® during bovine alphaherpesvirus 1 infection
In conclusion, our findings indicate that Taurisolo® may represent a potential antiviral agent against BoAHV-1 infection. Noteworthy, AhR could be involved in the observed effects and become a new target in antiviral therapy.PMID:37666327 | DOI:10.1016/j.virusres.2023.199217
Source: Virus Research - September 4, 2023 Category: Virology Authors: Claudia Cerracchio Maria Grazia Amoroso Marialuisa Piccolo Maria Grazia Ferraro Francesca Paola Nocera Luisa De Martino Francesco Serra Carlo Irace Gian Carlo Tenore Ettore Novellino Rita Santamaria Filomena Fiorito Source Type: research
Antiviral therapy of coronavirus disease 2019 (COVID-19)
J Formos Med Assoc. 2023 Sep 2:S0929-6646(23)00342-X. doi: 10.1016/j.jfma.2023.08.029. Online ahead of print.ABSTRACTThe coronavirus disease 2019 (COVID-19) pandemic has reached a turning point. The non-pharmaceutical interventions for preventing COVID-19 are lifting. Vaccination uptake is increasing in general, but this strategy is continuously challenged by the rapid evolution of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Of note, the Omicron subvariants spread globally for at least one year, and the most recently developed subvariants show strong immune evasion to preexisting immunity, either from pre...
Source: J Formos Med Assoc - September 4, 2023 Category: General Medicine Authors: Pao-Yu Chen Jann-Tay Wang Shan-Chwen Chang Source Type: research
Research Progress in Nanopharmaceuticals with Different Delivery Routes in the Antivirus Field
Curr Pharm Des. 2023 Aug 30. doi: 10.2174/1381612829666230830105817. Online ahead of print.ABSTRACTHuman health is significantly threatened by infectious diseases caused by viral infection. Over the years, there have been numerous virus epidemics worldwide, causing millions of deaths. Traditional antiviral medications have many problems, including poor solubility and antiviral resistance. Additionally, because different drug delivery methods have different biological barriers to overcome, the drug's bioavailability will be significantly affected. Therefore, it is essential that researchers create more effective antiviral d...
Source: Current Pharmaceutical Design - August 30, 2023 Category: Drugs & Pharmacology Authors: Yenong Shi Dongqiong He Xianwei Zhang Mingqing Yuan Xu Liu Source Type: research
